Skip to content

Planned Semi-Elective Lung Tx Study

Planned Semi-Elective Lung Transplantation Using 10°C Cold Static Preservation: A Proof-Of-Concept Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04616365
Enrollment
70
Registered
2020-11-04
Start date
2020-08-26
Completion date
2023-04-21
Last updated
2023-12-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Transplantation

Brief summary

In the current practice of lung transplantation, transplants are performed on a 24/7 schedule with a significant amount of procedures occurring overnight in order to minimize organ ischemic time. However, transplantation during the day time may lead to several advantages related to patient safety, including the presence of rested staff performing optimally, larger number of in-house professionals for emergency situations, and professional well-being. Advances and refinements in preservation practices have evolved to show that extended periods of preservation can be achieved without compromising outcome. Based on this, it is hypothesized that the avoidance of nighttime lung transplantation through prolonged pulmonary preservation will lead to at least similar patient outcomes compared to the current practice of 24/7 transplantation. During the period of this study, overnight transplants will be moved to a later start time (earliest 6AM). If lungs meet criteria for direct transplantation, they will be preserved with cold static preservation at 10°C within a special refrigerator. The maximum preservation time from donor cold flush to recipient anesthesia start time will be 12 hours.

Interventions

PROCEDURESemi-Elective Lung Transplantation

When suitable donor lungs become available for a consented recipient, the transplant procedure (anesthesia starting time) will be allowed to begin earliest at 6am with the lungs being preserved at 10°C cold static preservation upon organ arrival to our hospital using a specific incubator, regardless of when donor cross clamp occurs. The maximum time allowed between donor cross clamp and recipient anesthesia initiation will be 12h.

Sponsors

University Health Network, Toronto
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

Recipient inclusion criteria * Primary lung transplantation * Informed consent provided * 18-80 years old Recipient

Exclusion criteria

* Re-transplantation * Multi-organ transplantation * \>80 years old Donor inclusion criteria * Age ≤70 years old * Donor lungs are suitable to go straight to lung transplantation Donor

Design outcomes

Primary

MeasureTime frame
Incidence of ISHLT Primary Graft Dysfunction Grade 372 hours post-transplant

Secondary

MeasureTime frame
Time on ventilatorPerioperative
ICU and hospital length of stayPerioperative
Overall survival30 days, 1 year post-transplant
Six minute walk test1 year post-transplant
Forced expiratory volume - one second (FEV1 in L)1 year post-transplant
Occurrence of acute rejection1 year post-transplant

Countries

Austria, Canada, Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 12, 2026